Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a **pseudogene** of the PH domain and leucine-rich repeat protein phosphatase 2 (*PHLPP2*), labeled "ENSG00000261017"[1]. Pseudogenes are genetic elements that have lost the ability to code for functional protein due to mutations, deletions, or truncations. Unlike the functional PHLPP2 enzyme, which is a serine/threonine phosphatase involved in regulating cellular signaling pathways, the PHLPP2 pseudogene does not encode a functional protein and has no recognized biological or pharmacological activity. As such, it is not considered a therapeutic target and should not be confused with its protein-coding counterpart.\n\nIf you intended information on the **actual enzyme**, search for "PH domain and leucine-rich repeat protein phosphatase 2 (PHLPP2)" instead of the pseudogene[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PH domain and leucine-rich repeat protein phosphatase 2 pseudogene (PHLPP2 pseudogene).